Jim Simons's position in Neumora Therapeutics is currently worth $714k. That's 0.00% of their equity portfolio (2298th largest holding). The investor owns 1.04% of the outstanding Neumora Therapeutics stock. The first Neumora Therapeutics trade was made in Q4 2023. Since then Jim Simons bought shares four more times and sold shares on four occasions. The investor's estimated purchase price is $2.15M, resulting in a loss of 67%.